The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
telavancin hydrochloride · TELAVANCIN HYDROCHLORIDE 15 mg/mL · Injection, Powder, Lyophilized, For Solution · Intravenous · Cumberland Pharmaceuticals Inc.
NDC 66220-0315-11 · 1 VIAL, SINGLE-DOSE in 1 CARTON / 50 mL in 1 VIAL, SINGLE-DOSE · NDA · View full market →
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Not scored — fragility is computed for NADAC-priced NDCs.
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
There's no legal definition — it meets 2 of 6 public criteria. Why that matters →
| Type | Number / code | Expires |
|---|---|---|
| patent | 7531623 | Jan 1, 2027 |
| patent | 7531623 | Jan 1, 2027 |
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Cumberland Pharmaceuticals Inc. | TELAVANCIN HYDROCHLORIDE 15 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Vibativ — NDC 66220-0315-11," retrieved September 3, 2026, https://drugdashboards.com/drug/66220031511.
Free to cite with attribution — see how the data is put together.